The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion
Open Access
- 23 February 1995
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (8) , 488-493
- https://doi.org/10.1056/nejm199502233320802
Abstract
Patients with coronary artery disease and abnormalities of serum lipid levels often have endothelial vasodilator dysfunction, which may contribute to ischemic cardiac events. Whether cholesterol-lowering or antioxidant therapy can restore endothelium-dependent coronary vasodilatation is unknown.Keywords
This publication has 25 references indexed in Scilit:
- The L-Arginine-Nitric Oxide PathwayNew England Journal of Medicine, 1993
- Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.Circulation, 1993
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteinsNature, 1990
- Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.Circulation, 1990
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research GroupJAMA, 1982
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971